The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Based on the patient's clinical characteristics and laboratory indicators, different machine‐learning methods were used to develop models for predicting the negative conversion time of nonsevere coronavirus disease 2019 (COVID‐19) patients. A retrospective analysis was performed on 376 nonsevere COVID‐19 patients admitted to Wuxi Fifth People's Hospital from May 2, 2022, to May 14, 2022. The patients...
Amantadine, an antiviral drug, has been widely used in human anti‐influenza treatments. However, several highly pathogenic avian influenza viruses show amantadine‐resistance mutations in the viral matrix 2 (M2) protein. Here we analyzed global H5N1 sequencing data and calculate possible correlations between frequencies of key mutations in M2 and the mortality rates. We found that the frequency of...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.